About Alzamend Neuro (ALZN)
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic ... Read more
- USD3.53
- USD3.55
- USD3.45
- USD135.54
- -41.60%
- --
- 44.03k
- 370.52k
- 3M
- 3.06
- -93.80%
Stock News
4 hours ago
VHT Looks Attractive, And Risks May Be Overestimated
SeekingAlpha
yesterday
Sales at Urban Outfitters’ namesake stores make a rare gain, shrugging off tariff impact for now
MarketWatch
yesterday
White House crypto czar David Sacks says stablecoin bill will unlock 'trillions' for U.S. Treasury
CNBC
yesterday
Jim Cramer says to have 'patience' as Wall Street frets over higher bond yields and federal budget bill
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
